Macquarie Initiates Coverage on Privia Health Group (NASDAQ:PRVA)

Macquarie assumed coverage on shares of Privia Health Group (NASDAQ:PRVA - Free Report) in a research report report published on Monday morning, Marketbeat reports. The brokerage issued an outperform rating and a $25.00 price objective on the stock.

PRVA has been the topic of several other research reports. Robert W. Baird raised their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the company an "outperform" rating in a report on Monday, August 26th. KeyCorp initiated coverage on shares of Privia Health Group in a report on Friday, October 11th. They set an "overweight" rating and a $23.00 target price on the stock. Barclays increased their price target on Privia Health Group from $19.00 to $21.00 and gave the company an "equal weight" rating in a report on Friday, November 8th. Truist Financial boosted their price objective on Privia Health Group from $24.00 to $27.00 and gave the stock a "buy" rating in a research note on Friday, November 8th. Finally, JPMorgan Chase & Co. increased their target price on Privia Health Group from $27.00 to $28.00 and gave the company an "overweight" rating in a research note on Friday, November 29th. Two research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, Privia Health Group has an average rating of "Buy" and an average price target of $24.80.

Privia Health Group Trading Up 4.3 %

NASDAQ:PRVA traded up $0.91 on Monday, hitting $21.87. 584,983 shares of the stock were exchanged, compared to its average volume of 837,719. The stock has a market cap of $2.62 billion, a PE ratio of 209.62, a PEG ratio of 5.45 and a beta of 0.83. Privia Health Group has a fifty-two week low of $15.92 and a fifty-two week high of $24.30. The stock has a fifty day moving average of $19.96 and a 200-day moving average of $19.04.

Hedge Funds Weigh In On Privia Health Group

A number of hedge funds have recently bought and sold shares of the company. Canada Pension Plan Investment Board acquired a new position in shares of Privia Health Group in the 2nd quarter worth approximately $26,000. Nisa Investment Advisors LLC boosted its holdings in Privia Health Group by 107.5% in the second quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company's stock worth $31,000 after purchasing an additional 930 shares during the period. GAMMA Investing LLC boosted its holdings in Privia Health Group by 98.7% in the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company's stock worth $31,000 after purchasing an additional 845 shares during the period. Signaturefd LLC increased its stake in Privia Health Group by 46.3% during the second quarter. Signaturefd LLC now owns 1,978 shares of the company's stock valued at $34,000 after purchasing an additional 626 shares during the last quarter. Finally, Quarry LP raised its holdings in shares of Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company's stock worth $60,000 after purchasing an additional 2,533 shares during the period. 94.48% of the stock is currently owned by institutional investors and hedge funds.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.